Small-interfering RNA-mediated silencing of the MAPK p42 gene induces dual effects in HeLa cells

Jing-Yi Yuan1, Li-Ying Liu, Pei Wang

  • 1Department of Genetics and Molecular Biology, Medical School of Xi'an Jiaotong University/Key Laboratory of Environment and Genes Related to Diseases, Xi'an Jiaotong University, Ministry of Education, Shaanxi 710061.

Oncology Letters
|September 12, 2012
PubMed

Insights

Small-interfering RNAs (siRNAs) targeting MAPK p42 inhibit cervical cancer cell growth more effectively than U0126. MAPK p42 siRNA induces cell cycle arrest at S phase and an interferon-like response, unlike U0126.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • Cervical cancer progression involves oncogene activation and tumor suppressor gene inactivation.
  • Small-interfering RNAs (siRNAs) targeting MAPK p42 have shown potential in inhibiting HeLa cell proliferation and inducing apoptosis.

Purpose of the Study:

  • To confirm the dual effects of MAPK p42 siRNA and compare its role with U0126, a MAPK p42 inhibitor, in HeLa cells.
  • To investigate the specific mechanisms of growth inhibition and cell cycle regulation induced by MAPK p42 siRNA.

Main Methods:

  • siRNAs targeting MAPK p42 mRNA were synthesized and transfected into HeLa cells.
  • Cells were treated with siRNA or U0126, and biological effects were measured using MTT and flow cytometry.
  • Gene expression analysis (MAPK1, NUP188, P38, STAT1, STAT2, PML, OAS1) was performed using real-time quantitative PCR.

Main Results:

  • Both siRNA and U0126 inhibited HeLa cell growth, with siRNA showing a greater effect.
  • siRNA induced S phase arrest, while U0126 induced G1 phase arrest.
  • siRNA-mediated MAPK p42 silencing resulted in distinct gene expression changes compared to U0126 treatment, including P38 upregulation and NUP188 downregulation, and an interferon-like response.

Conclusions:

  • siRNA-mediated silencing of MAPK p42 effectively inhibits HeLa cell growth, exhibiting dual effects including specific gene silencing and a non-specific interferon-like response.
  • The distinct cell cycle arrest phases and gene expression profiles highlight the differential mechanisms of action between siRNA and U0126.
  • MAPK p42 siRNA represents a potent therapeutic strategy for cervical cancer, with effects differing from chemical inhibitors.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...